Additionally, studies by Oshi et al. in two large cohorts of BC patients with high glycolysis scores showed a poor prognosis in TNBC subtype, but not in ER-positive/HER2-negative BC, potentially suggesting that counterbalance of other distinct hallmark of BC subtypes signaling may affect patient prognosis [188]. This evidence concerns the gene ERBB2 and breast cancer.